How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
A Phase 2, Open-label, Non-randomized, Single Center Study Evaluating 18F-Fluoroestradiol Positron Emission Tomography/Computed Tomography for the Detection of Distant Metastases in Low-grade, Estrogen Receptor-positive Stage III Breast Cancer
Description:
This study aims to evaluate the detection rate of distant metastases using [18F]FES PET/CT in patients with low-grade, ER-positive stage III breast cancer.
Sponsor:
Asan Medical Center
Contacts:
Sangwon Hanhswon87@amc.seoul.kr
+82-2-3010-0657
Jaeeun Kimkje0216@amc.seoul.kr
+82-2-3010-4572
Government Study Link:
NCT07314073 - Click here to see study onClinicalTrials.gov
18F-FES
Isotope(s):
Target(s):
- Estrogen Receptor
